Photoradiation therapy causing selective tumor kill in a rat glioma model
- PMID: 2952899
- DOI: 10.1227/00006123-198703000-00009
Photoradiation therapy causing selective tumor kill in a rat glioma model
Abstract
We evaluated the effect of photoradiation therapy using the photosensitizer, hematoporphyrin derivative (HpD), and the argon-pumped rhodamine dye laser tuned to 630 nm in the rat C6 glioma model. Animal models of cerebral glioma were established by implanting 10(6) C6 glioma cells in adult Wistar rats, and craniotomies were performed on normal and tumor-bearing animals. HpD in doses of up to 80 mg/kg followed by craniotomy resulted in no damage to the normal brain, and laser light at doses of up to 1200 joules/cm2 without the prior administration of HpD produced no significant damage if the craniotomy site was irrigated with normal saline to prevent a temperature rise. Photoradiation caused no brain necrosis in non-tumor bearing animals if less than 20 mg of HpD per kg and 200 joules of red light per cm2 were used. At higher doses of HpD and light, cerebral necrosis did occur. The depth of necrosis depended on the dose of both HpD and light. Treatment with 40 mg of HpD per kg and 400 joules of light per cm2 resulted in cerebral necrosis in 50% of the treated animals. The mean depth of brain necrosis was 1.3 mm. Selective kill of a cerebral glioma with sparing of the normal brain was achieved with photoradiation therapy at doses of HpD of less than 20 mg/kg and light doses of less than 200 joules/cm2. At these doses, the mean depth of tumor kill was 4.5 mm. In 2 of 10 animals, the depth of tumor destruction was more than 6 mm.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Effects of photoradiation therapy on normal rat brain.Neurosurgery. 1984 Dec;15(6):804-10. Neurosurgery. 1984. PMID: 6239989
-
Effect of hematoporphyrin derivative photoradiation therapy on survival in the rat 9L gliosarcoma brain-tumor model.J Neurosurg. 1985 Dec;63(6):917-21. doi: 10.3171/jns.1985.63.6.0917. J Neurosurg. 1985. PMID: 2932542
-
Hematoporphyrin derivative photoradiation therapy of the rat 9L gliosarcoma brain tumor model.Lasers Surg Med. 1984;4(1):99-105. doi: 10.1002/lsm.1900040114. Lasers Surg Med. 1984. PMID: 6235423
-
Photoradiation therapy and its potential in the management of neurological tumors.J Neurosurg. 1988 Jul;69(1):1-14. doi: 10.3171/jns.1988.69.1.0001. J Neurosurg. 1988. PMID: 3288722 Review.
-
A review of photoradiation therapy in the management of central nervous system tumours.Aust N Z J Surg. 1988 Oct;58(10):767-80. doi: 10.1111/j.1445-2197.1988.tb00979.x. Aust N Z J Surg. 1988. PMID: 3074764 Review.
Cited by
-
Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy.Br J Cancer. 1994 Sep;70(3):398-400. doi: 10.1038/bjc.1994.316. Br J Cancer. 1994. PMID: 8080721 Free PMC article.
-
In vivo magnetic resonance imaging of the effects of photodynamic therapy.Br J Cancer. 1989 Aug;60(2):164-7. doi: 10.1038/bjc.1989.244. Br J Cancer. 1989. PMID: 2765361 Free PMC article.
-
Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1785-9. doi: 10.1073/pnas.89.5.1785. Proc Natl Acad Sci U S A. 1992. PMID: 1542672 Free PMC article.
-
Vascular function and the probability of skin necrosis after photodynamic therapy: an experimental study.Br J Cancer. 1988 May;57(5):451-4. doi: 10.1038/bjc.1988.105. Br J Cancer. 1988. PMID: 3395550 Free PMC article.
-
The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.Br J Cancer. 1996 Feb;73(3):332-43. doi: 10.1038/bjc.1996.58. Br J Cancer. 1996. PMID: 8562339 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical